Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 3 |
2021 | 3 |
2022 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Clinically encountered growth phenotypes of tuberculosis-causing bacilli and their in vitro study: A review.
Front Cell Infect Microbiol. 2022 Nov 10;12:1029111. doi: 10.3389/fcimb.2022.1029111. eCollection 2022.
Front Cell Infect Microbiol. 2022.
PMID: 36439231
Free PMC article.
Review.
Transcriptional Biomarkers of Differentially Detectable Mycobacterium tuberculosis in Patient Sputum.
Zainabadi K, Saito K, Mishra S, Walsh KF, Mathurin LD, Vilbrun SC, Ocheretina O, Pape JW, Fitzgerald DW, Nathan CF, Lee MH.
Zainabadi K, et al.
mBio. 2022 Dec 20;13(6):e0270122. doi: 10.1128/mbio.02701-22. Epub 2022 Nov 3.
mBio. 2022.
PMID: 36326252
Free PMC article.
Item in Clipboard
Oxidative damage and delayed replication allow viable Mycobacterium tuberculosis to go undetected.
Saito K, Mishra S, Warrier T, Cicchetti N, Mi J, Weber E, Jiang X, Roberts J, Gouzy A, Kaplan E, Brown CD, Gold B, Nathan C.
Saito K, et al.
Sci Transl Med. 2021 Nov 24;13(621):eabg2612. doi: 10.1126/scitranslmed.abg2612. Epub 2021 Nov 24.
Sci Transl Med. 2021.
PMID: 34818059
Free PMC article.
Item in Clipboard
Characterization of Differentially Detectable Mycobacterium tuberculosis in the Sputum of Subjects with Drug-Sensitive or Drug-Resistant Tuberculosis before and after Two Months of Therapy.
Zainabadi K, Walsh KF, Vilbrun SC, Mathurin LD, Lee MH, Saito K, Mishra S, Ocheretina O, Pape JW, Nathan C, Fitzgerald DW.
Zainabadi K, et al.
Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0060821. doi: 10.1128/AAC.00608-21. Epub 2021 Jul 16.
Antimicrob Agents Chemother. 2021.
PMID: 34060896
Free PMC article.
Item in Clipboard
Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression.
Rendeiro AF, Casano J, Vorkas CK, Singh H, Morales A, DeSimone RA, Ellsworth GB, Soave R, Kapadia SN, Saito K, Brown CD, Hsu J, Kyriakides C, Chiu S, Cappelli LV, Cacciapuoti MT, Tam W, Galluzzi L, Simonson PD, Elemento O, Salvatore M, Inghirami G.
Rendeiro AF, et al.
Life Sci Alliance. 2020 Dec 24;4(2):e202000955. doi: 10.26508/lsa.202000955. Print 2021 Feb.
Life Sci Alliance. 2020.
PMID: 33361110
Free PMC article.
Item in Clipboard
Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression.
Rendeiro AF, Casano J, Kyriakos Vorkas C, Singh H, Morales A, DeSimone RA, Ellsworth GB, Soave R, Kapadia SN, Saito K, Brown CD, Hsu J, Kyriakides C, Chiu S, Cappelli L, Teresa Cacciapuoti M, Tam W, Galluzzi L, Simonson PD, Elemento O, Salvatore M, Inghirami G.
Rendeiro AF, et al.
medRxiv [Preprint]. 2020 Sep 9:2020.09.08.20189092. doi: 10.1101/2020.09.08.20189092.
medRxiv. 2020.
PMID: 32935114
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Early Bactericidal Activity Trial of Nitazoxanide for Pulmonary Tuberculosis.
Walsh KF, McAulay K, Lee MH, Vilbrun SC, Mathurin L, Jean Francois D, Zimmerman M, Kaya F, Zhang N, Saito K, Ocheretina O, Savic R, Dartois V, Johnson WD, Pape JW, Nathan C, Fitzgerald DW.
Walsh KF, et al.
Antimicrob Agents Chemother. 2020 Apr 21;64(5):e01956-19. doi: 10.1128/AAC.01956-19. Print 2020 Apr 21.
Antimicrob Agents Chemother. 2020.
PMID: 32071052
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite